9Kumpulainen EJ, Keskikuru RJ, Johansson RT, et al. Serum tumor marker CA153 and stage are the two most powerful predictors of survival in primary breast cancer[J]. Breast Cancer Res Treat, 2002,76(2) :95 -102.
10Duffy MJ, Duggan C, Keane R, et al. High preoperative CA153 concentrations predict adverse outcome in node-nega tive and node-positive breast cancer: study of 600 patients with histologically confirmed breast cancer[J]. Clin Chem, 2004, 50(3) :559 -563.
1Hennessy BT,Hortobagyi GN,Rouzier R,et al.Outcome after athologic complete eradication of cytologically proven breastcan-cer axillary node metastases following primary chemotherapy.J Clin Oncol,2005,23(36):9304-9308.
2Dupont WD,Parl FF,Hartmann WH,et al.Breast cancer risk associated with proliferative breast disease and atypical hyperplasia[].Cancer.1993
3CE Rogler,D Yang,L Rossetti,J Donohoe,E Alt,CJ Chang,R Rosenfeld,K Neely,R Hin.Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice[].Journal of Biological Chemistry.1994
4Hennessy Bryan T,Hortobagyi Gabriel N,Rouzier Roman,Kuerer Henry,Sneige Nour,Buzdar Aman U,Kau Shu Wan,Fornage Bruno,Sahin Aysegul,Broglio Kristine,Singletary S Eva,Valero Vicente.Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy[].Journal of clinical oncology : official journal of the American Society of Clinical Oncology.2005
